514 related articles for article (PubMed ID: 25729034)
1. Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) - Report from OMERACT CTD-ILD Working Group.
Khanna D; Mittoo S; Aggarwal R; Proudman SM; Dalbeth N; Matteson EL; Brown K; Flaherty K; Wells AU; Seibold JR; Strand V
J Rheumatol; 2015 Nov; 42(11):2168-71. PubMed ID: 25729034
[TBL] [Abstract][Full Text] [Related]
2. Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases.
Saketkoo LA; Mittoo S; Frankel S; LeSage D; Sarver C; Phillips K; Strand V; Matteson EL; ;
J Rheumatol; 2014 Apr; 41(4):792-8. PubMed ID: 24488412
[TBL] [Abstract][Full Text] [Related]
3. Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 process.
Roofeh D; Barratt SL; Wells AU; Kawano-Dourado L; Tashkin D; Strand V; Seibold J; Proudman S; Brown KK; Dellaripa PF; Doyle T; Leonard T; Matteson EL; Oddis CV; Solomon JJ; Sparks JA; Vassallo R; Maxwell L; Beaton D; Christensen R; Townsend W; Khanna D
Semin Arthritis Rheum; 2021 Dec; 51(6):1331-1341. PubMed ID: 34493396
[TBL] [Abstract][Full Text] [Related]
4. Assessment and management of connective tissue disease-associated interstitial lung disease.
Fischer A; Chartrand S
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):2-21. PubMed ID: 26237351
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials.
Saketkoo LA; Mittoo S; Huscher D; Khanna D; Dellaripa PF; Distler O; Flaherty KR; Frankel S; Oddis CV; Denton CP; Fischer A; Kowal-Bielecka OM; LeSage D; Merkel PA; Phillips K; Pittrow D; Swigris J; Antoniou K; Baughman RP; Castelino FV; Christmann RB; Christopher-Stine L; Collard HR; Cottin V; Danoff S; Highland KB; Hummers L; Shah AA; Kim DS; Lynch DA; Miller FW; Proudman SM; Richeldi L; Ryu JH; Sandorfi N; Sarver C; Wells AU; Strand V; Matteson EL; Brown KK; Seibold JR;
Thorax; 2014 May; 69(5):428-36. PubMed ID: 24368713
[TBL] [Abstract][Full Text] [Related]
6. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
7. Interstitial lung disease evaluation: detecting connective tissue disease.
Fischer A; Lee JS; Cottin V
Respiration; 2015; 90(3):177-84. PubMed ID: 26343272
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.
Singh P; Thakur B; Mohapatra AK; Padhan P
Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423
[TBL] [Abstract][Full Text] [Related]
9. Identification and management of connective tissue disease-associated interstitial lung disease: evidence-based Japanese consensus statements.
Kuwana M; Bando M; Kawahito Y; Sato S; Suda T; Kondoh Y;
Expert Rev Respir Med; 2023 Jan; 17(1):71-80. PubMed ID: 36786105
[TBL] [Abstract][Full Text] [Related]
10. Developing disease activity and response criteria in connective tissue disease-related interstitial lung disease.
Saketkoo LA; Matteson EL; Brown KK; Seibold JR; Strand V;
J Rheumatol; 2011 Jul; 38(7):1514-8. PubMed ID: 21724725
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics of Connective Tissue Disease-Associated Interstitial Lung Disease in 1,044 Chinese Patients.
Hu Y; Wang LS; Wei YR; Du SS; Du YK; He X; Li N; Zhou Y; Li QH; Su YL; Zhang F; Shen L; Weng D; Brown KK; Li HP
Chest; 2016 Jan; 149(1):201-8. PubMed ID: 26447566
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and risk factors of interstitial pneumonia with autoimmune features.
Vahidy S; Agyeman J; Zheng B; Donohoe K; Hambly N; Johannson KA; Assayag D; Fisher JH; Manganas H; Marcoux V; Khalil N; Kolb M; Ryerson CJ; ; Wong AW; Lok S; Morisset J; Fell CD; Shapera S; Gershon AS; Cox G; Halayko AJ; Sadatsafavi M; Wilcox PG; To T
Respir Med; 2024 Jan; 221():107500. PubMed ID: 38142756
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
[TBL] [Abstract][Full Text] [Related]
14. Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial.
Saunders P; Tsipouri V; Keir GJ; Ashby D; Flather MD; Parfrey H; Babalis D; Renzoni EA; Denton CP; Wells AU; Maher TM
Trials; 2017 Jun; 18(1):275. PubMed ID: 28619061
[TBL] [Abstract][Full Text] [Related]
15. Rituximab for connective tissue disease-associated interstitial lung disease: A systematic review and meta-analysis.
Wang Y; Li L
Int J Rheum Dis; 2023 Feb; 26(2):225-235. PubMed ID: 36378118
[TBL] [Abstract][Full Text] [Related]
16. Lung Cancer development and mortality in interstitial lung disease with and without connective tissue diseases: a five-year Nationwide population-based study.
Choi WI; Lee DY; Choi HG; Lee CW
Respir Res; 2019 Jun; 20(1):117. PubMed ID: 31182103
[TBL] [Abstract][Full Text] [Related]
17. Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study.
Pan L; Liu Y; Sun R; Fan M; Shi G
Clin Dev Immunol; 2013; 2013():121578. PubMed ID: 24171031
[TBL] [Abstract][Full Text] [Related]
18. Management of interstitial lung disease associated with connective tissue disease.
Mathai SC; Danoff SK
BMJ; 2016 Feb; 352():h6819. PubMed ID: 26912511
[TBL] [Abstract][Full Text] [Related]
19. Connective tissue disease--associated interstitial lung disease: an underreported cause of interstitial lung disease in Sub-Saharan Africa.
Olaosebikan H; Adeyeye O; Akintayo R; Akpabio A; Adenitan A; Adelowo O; Ojo O; Abimbola FO
Clin Rheumatol; 2021 Sep; 40(9):3455-3460. PubMed ID: 32803569
[TBL] [Abstract][Full Text] [Related]
20. Management of connective tissue diseases associated interstitial lung disease: a review of the published literature.
Wallace B; Vummidi D; Khanna D
Curr Opin Rheumatol; 2016 May; 28(3):236-45. PubMed ID: 27027811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]